These findings fly in the face of robust and mounting evidence demonstrating the efficacy of SGLTi and GLP1-RA in reducing progression of diabetes complications, and the recommendations of Diabetes Canada [4] and other major professional organizations [14, 19, 20]. The gene discussed is GLP1R; the disease is diabetes mellitus.